Response to adalimumab in patients with early versus late rheumatoid arthritis (RA)

被引：0
|
作者：
Keystone, E
Kavanaugh, A
Fischkoff, S
机构：
[1] Mt Sinai Hosp, Ctr Adv Therapeut, Toronto, ON M5G 1X5, Canada
[2] UCSD, Div Rheumatol, La Jolla, CA USA
[3] Abbott Labs, ImmunoSci Dev Ctr, Parsippany, NJ USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [1] Early clinical response in venezuelan patients with rheumatoid arthritis (RA) treated with adalimumab
    Pena, N.
    Briceno, F.
    Franco, L. M.
    Herrera, J. A.
    Marin, F.
    Millan, A.
    Paul-Moya, H.
    Perez, P.
    Rodriguez, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 496 - 497
  • [2] Reduced TNF utilization in early rheumatoid arthritis (RA) versus late RA in a US cohort
    Yazici, Y.
    Greenberg, J.
    Reed, G.
    Kishimoto, M.
    Hinkle, K.
    Abramson, S.
    Kremer, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 513 - 513
  • [3] Workplace impacts of adalimumab (HUMIRA®) in patients with rheumatoid arthritis (RA)
    Birnbaum, Howard
    Pike, Crystal
    Kaufman, Rebecca
    Schiller, Matthew
    Shi, Lizheng
    Sun, Peter
    Ray, Saurabh
    Cifaldi, Mary
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S459 - S459
  • [4] Effect of adalimumab (humira®) on response to influenza virus and pneumococcal vaccines in patients with rheumatoid arthritis (RA)
    Kaine, J.
    Kivitz, A.
    Birbara, C.
    Luo, A. Y.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 304 - 304
  • [5] Adalimumab for early rheumatoid arthritis
    Bykerk, Vivian Patricia
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2008, 4 (02) : 157 - 163
  • [6] Health economic evaluation of patients with rheumatoid arthritis (RA) treated with adalimumab
    Vanoverbeke, N
    Annemans, L
    Cauchie, P
    Hendrickx, E
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 663 - 663
  • [7] Remission and major clinical response in active rheumatoid arthritis (RA) patients after adalimumab (Humira®) treatment
    Burmester, G. M.
    Wordsworth, P.
    McKenna, F.
    Farraccioli, G. F.
    Flipo, R. -M.
    Kary, S.
    Kupper, H.
    [J]. RHEUMATOLOGY, 2007, 46 : I28 - I29
  • [8] Remission and major clinical response in patients with active rheumatoid arthritis (RA) after treatment with adalimumab (Humira®).
    Burmester, G. M.
    Ferraccioli, G. F.
    Flipo, R-M
    Kary, S.
    Kupper, H.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S377 - S377
  • [9] Adalimumab response in patients with early versus established rheumatoid arthritis: DE019 randomized controlled trial subanalysis
    Jamal, Shahin
    Patra, Kaushik
    Keystone, Edward C.
    [J]. CLINICAL RHEUMATOLOGY, 2009, 28 (04) : 413 - 419
  • [10] Adalimumab response in patients with early versus established rheumatoid arthritis: DE019 randomized controlled trial subanalysis
    Shahin Jamal
    Kaushik Patra
    Edward C. Keystone
    [J]. Clinical Rheumatology, 2009, 28 : 413 - 419
12345